A reduction in EHHADH expression has been observed in mouse models for chronic kidney disease (Trudu et al., 2017), hyperlipidemia (Mirzoyan et al., 2017), obesity and fatty liver disease (Vandanmagsar et al., 2011). Here, EHHADH is linked to obesity disorder.